Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

Bibliographic Details
Main Authors: Nishan Tchekmedyian, MD, Bill Paxton, MD, PhD, Francois Lebel, MD, Lena Keossayan, BA, John V. Heymach, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320301041

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320301041

Similar Items